CinCor Pharma, Inc.
CINC · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $293 | $128 | $165 | $137 |
| Short-Term Investments | $230 | $167 | $150 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $9 | $7 | $5 |
| Total Curr. Assets | $529 | $303 | $322 | $141 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $529 | $303 | $322 | $141 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $4 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $5 | $1 | $16 |
| Total Curr. Liab. | $10 | $7 | $6 | $17 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $188 |
| Total NC Liab. | $3 | $2 | $4 | $188 |
| Other Liabilities | -$3 | -$2 | -$4 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $10 | $7 | $6 | $205 |
| Equity | – | – | – | – |
| Pref Stock | $529 | $303 | $322 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$136 | -$115 | -$94 | -$78 |
| AOCI | -$1 | -$1 | -$0 | $0 |
| Other Equity | $656 | $412 | $411 | $14 |
| Total Equity | $519 | $296 | $316 | -$64 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $529 | $303 | $322 | $141 |
| Net Debt | -$293 | -$128 | -$165 | -$137 |